Bank of New York Mellon’s NanoViricides NNVC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-1,909
Closed -$10K 4259
2019
Q1
$10K Sell
1,909
-58
-3% -$378 ﹤0.01% 4195
2018
Q4
$8K Hold
1,967
﹤0.01% 4203
2018
Q3
$14K Hold
1,967
﹤0.01% 4223
2018
Q2
$17K Hold
1,967
﹤0.01% 4181
2018
Q1
$32K Sell
1,967
-95
-5% -$1.76K ﹤0.01% 4231
2017
Q4
$37K Sell
2,062
-191
-8% -$3.91K ﹤0.01% 4240
2017
Q3
$52K Hold
2,253
﹤0.01% 4096
2017
Q2
$61K Sell
2,253
-141
-6% -$3.48K ﹤0.01% 4108
2017
Q1
$53K Buy
2,394
+141
+6% +$3.29K ﹤0.01% 4129
2016
Q4
$48K Sell
2,253
-158
-7% -$4.21K ﹤0.01% 4135
2016
Q3
$82K Sell
2,411
-361
-13% -$12K ﹤0.01% 4080
2016
Q2
$88K Buy
2,772
+20
+0.7% +$730 ﹤0.01% 4083
2016
Q1
$120K Hold
2,752
﹤0.01% 3923
2015
Q4
$65K Hold
2,752
﹤0.01% 4143
2015
Q3
$65K Hold
2,752
﹤0.01% 4210
2015
Q2
$95K Sell
2,752
-5,885
-68% -$224K ﹤0.01% 4054
2015
Q1
$388K Buy
8,637
+156
+2% +$8.32K ﹤0.01% 3706
2014
Q4
$461K Sell
8,481
-155
-2% -$10.3K ﹤0.01% 3651
2014
Q3
$517K Buy
8,636
+331
+4% +$26K ﹤0.01% 3610
2014
Q2
$702K Buy
8,305
+6,401
+336% +$454K ﹤0.01% 3501
2014
Q1
$122K Sell
1,904
-286
-13% -$24.4K ﹤0.01% 3950
2013
Q4
$210K Buy
+2,190
New +$225K ﹤0.01% 3841

Other funds holding NNVC

Bank of New York Mellon's NNVC Position: Q2 2019 in Review

Bank of New York Mellon sold out of NanoViricides (NNVC) in Q2 2019, closing a stake of 1,909 shares — an estimated $10K sold.

Bank of New York Mellon first reported a position in NNVC in Q4 2013 and held it in 22 quarters. The position peaked at $702K in Q2 2014. 36 funds tracked by Wall St. Rank hold NNVC as of Q2 2019.

  • Bank of New York Mellon reported no remaining NanoViricides position as of Q2 2019 after selling out during the quarter.
  • Bank of New York Mellon sold 1,909 NanoViricides shares in Q2 2019, an estimated $10K.
  • Bank of New York Mellon first reported a position in NanoViricides in Q4 2013 and held it in 22 quarters.
  • Bank of New York Mellon's NanoViricides position peaked at $702K in Q2 2014.
  • 36 funds tracked by Wall St. Rank held NanoViricides as of Q2 2019.

Based on Bank of New York Mellon's 13F filing for Q2 2019, filed 12 Aug 2019.